Displaying 1 - 50 of 255 results
Released Company Title Industry Topic
23 Jan 2026
18:30 CET
UMICORE Umicore - Transparantieverklaring van BlackRock, Inc. 55201020 Specialty Chemicals New
23 Jan 2026
18:30 CET
UMICORE Umicore - Déclaration de transparence par BlackRock, Inc. 55201020 Specialty Chemicals New
23 Jan 2026
18:30 CET
UMICORE Umicore - Transparency notification by BlackRock, Inc. 55201020 Specialty Chemicals New
23 Jan 2026
18:00 CET
OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
23 Jan 2026
18:00 CET
OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
23 Jan 2026
08:15 CET
BEKAERT Bekaert - Update on the Share Buyback Program and Liquidity Agreement 55102010 Iron and Steel Legal
23 Jan 2026
08:15 CET
BEKAERT Bekaert - Update over het Inkoopprogramma van Eigen Aandelen en Liquiditeitsovereenkomst 55102010 Iron and Steel Legal
23 Jan 2026
07:30 CET
ONWARD MEDICAL ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer 20102010 Medical Equipment -
23 Jan 2026
07:00 CET
BIOTALYS NV Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production 55201015 Fertilizers -
22 Jan 2026
18:00 CET
HYBRID SOFTWARE GROUP PLC Update on the share repurchase program 10101015 Software Share history
22 Jan 2026
17:50 CET
VIOHALCO Publication relative aux notifications de transparence 55102015 Metal Fabricating Other subject
22 Jan 2026
17:50 CET
VIOHALCO Publication of transparency notifications 55102015 Metal Fabricating Other subject
22 Jan 2026
17:48 CET
VIOHALCO Nomination d’un nouveau Président et d’un nouveau Vice-Président du Conseil d’administration 55102015 Metal Fabricating Other subject
22 Jan 2026
17:47 CET
VIOHALCO Appointment of new Chairman and new Vice-Chairman of the Board of Directors 55102015 Metal Fabricating Other subject
22 Jan 2026
10:30 CET
ONTEX GROUP Ontex lanceert multi-liquid liner in Europa, afgestemd op de noden van vrouwen in perimenopauze en menopauze 45201020 Personal Products Other subject
22 Jan 2026
10:30 CET
ONTEX GROUP Ontex launches multi-liquid liner in Europe, empowering women in perimenopause and menopause 45201020 Personal Products Other subject
22 Jan 2026
07:30 CET
ONWARD MEDICAL ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement 20102010 Medical Equipment -
21 Jan 2026
22:05 CET
NYXOAH SA Nyxoah Investit Dans l'Expansion De Sa Capacité De Production En Belgique Afin De Soutenir Sa Croissance Mondiale 20102010 Medical Equipment Other subject
21 Jan 2026
22:05 CET
NYXOAH SA Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth 20102010 Medical Equipment Other subject
21 Jan 2026
18:00 CET
ION BEAM APPLICATIONS IBA SA – NOTIFICATION TRANSPARENCE 20102010 Medical Equipment Legal
21 Jan 2026
18:00 CET
ION BEAM APPLICATIONS IBA – TRANSPARENCY NOTIFICATION 20102010 Medical Equipment Legal
21 Jan 2026
17:46 CET
AEDIFICA Aedifica NV/SA – Aedifica’s obtains approval from Belgian Competition Authority 35102010 Health Care REITs Takeover bids
21 Jan 2026
07:40 CET
OPTION GEREGLEMENTEERDE INFORMATIE - De wedergeboorte van Option 15101010 Telecommunications Equipment Other subject
21 Jan 2026
07:35 CET
OPTION REGULATED INFORMATION - The rebirth of Option 15101010 Telecommunications Equipment Other subject
20 Jan 2026
18:30 CET
UMICORE Umicore - Déclaration de transparence par BlackRock, Inc. 55201020 Specialty Chemicals Other subject
20 Jan 2026
18:30 CET
UMICORE Umicore - Transparantieverklaring van BlackRock, Inc. 55201020 Specialty Chemicals Other subject
20 Jan 2026
18:30 CET
UMICORE Umicore - Transparency notification by BlackRock, Inc. 55201020 Specialty Chemicals Other subject
20 Jan 2026
17:45 CET
KINEPOLIS GROUP Publication relative à une notification de transparence 40301010 Entertainment Corporate life
20 Jan 2026
17:45 CET
KINEPOLIS GROUP Openbaarmaking van een transparantiekennisgeving 40301010 Entertainment Corporate life
20 Jan 2026
17:45 CET
KINEPOLIS GROUP Publication of a transparency notification 40301010 Entertainment Corporate life
20 Jan 2026
17:45 CET
SOLVAY Notifications de participation par Morgan Stanley 55201000 Chemicals: Diversified Corporate life
20 Jan 2026
17:45 CET
SOLVAY Participation notifications by Morgan Stanley 55201000 Chemicals: Diversified Corporate life
20 Jan 2026
17:45 CET
SOLVAY Participatiemeldingen van Morgan Stanley 55201000 Chemicals: Diversified Corporate life
20 Jan 2026
08:25 CET
TITAN S.A. Programme de rachats d'actions 50101030 Cement Other subject
20 Jan 2026
08:24 CET
TITAN S.A. Share buyback programme 50101030 Cement Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy 30202010 Asset Managers and Custodians Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling 30202010 Asset Managers and Custodians Other subject
20 Jan 2026
07:30 CET
GIMV Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy 30202010 Asset Managers and Custodians Other subject
19 Jan 2026
21:44 CET
HYLORIS Hyloris Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets 20103010 Biotechnology Corporate life
19 Jan 2026
18:11 CET
GBL GBL – Transacties op GBL-aandelen 19-01-2026 30202000 Diversified Financial Services Other financial transaction
19 Jan 2026
18:10 CET
GBL GBL – Transactions sur actions propres 19-01-2026 30202000 Diversified Financial Services Other financial transaction
19 Jan 2026
18:09 CET
GBL GBL – Transactions on GBL shares 19-01-2026 30202000 Diversified Financial Services Other financial transaction
19 Jan 2026
18:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
19 Jan 2026
18:00 CET
OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
19 Jan 2026
17:45 CET
European Medical Solutions 50 M EUR DE CHIFFRE D'AFFAIRES ANNUEL 2025 EN CROISSANCE ORGANIQUE DE +11% 20103010 Biotechnology Legal
19 Jan 2026
08:00 CET
OXURION Oxurion annonce la suspension temporaire du programme de financement dédié à des investissements dans les actifs numériques et crypto-actifs 20103010 Biotechnology Legal
19 Jan 2026
08:00 CET
OXURION Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets 20103010 Biotechnology Legal
19 Jan 2026
07:00 CET
AGEAS Ageas annonce une mise à jour de la guidance du Résultat Opérationnel Net 30301010 Life Insurance Other financial transaction
19 Jan 2026
07:00 CET
AGEAS Ageas kondigt bijstelling aan van het verwachte Netto Operationeel Resultaat 30301010 Life Insurance Other financial transaction
19 Jan 2026
07:00 CET
AGEAS Ageas announces Net Operating Result guidance update 30301010 Life Insurance Other financial transaction